{
    "nct_id": "NCT03865589",
    "official_title": "Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome",
    "inclusion_criteria": "* Any patient undergoing a myeloablative conditioning regimen for HCT between 3/1/2019 and 12/31/2025 defined as one of the following:\n\n  * TBI >= 1200 cGy (fractionated)\n  * Cyclophosphamide + TBI (> 500 cGy (single) or > 800cGy (fractionated))\n  * Cyclophosphamide + Etoposide + TBI (> 500 cGy (single) or > 800 cGy (fractionated))\n  * Cyclophosphamide + Thiotepa + TBI (> 500 cGy (single) or > 800 cGy (fractionated))\n  * Busulfan (Total dose > 7.2 mg/kg IV or >9.0mg/kg orally) + Cyclophosphamide\n  * Busulfan (Total dose >7.2 mg/kg IV or >9.0 mg/kg orally) + Melphalan\n  * Busulfan (Total dose >7.2 mg/kg IV or >9.0 mg/kg orally) + Thiotepa\n  * NOTE: Busulfan cumulative plasma AUC of >75 mg/L per hour or >18270 microMolar per minute could be used in the preceding criteria in lieu of the mg/kg doses.\n\nOR\n\n2. Any patient who has a myeloablative conditioning regimen (as defined by the local HCT team) that includes sirolimus and tacrolimus for GVHD prophylaxis.\n\nOR\n\n3. Any patient who is high risk for SOS irrespective of conditioning regimen: Neuroblastoma, HLH, Osteopetrosis, Thalassemia, treatment with inotuzumab or gemtuzumab within 3 months prior to HCT admission, 2nd HCT if it is myeloablative and within 6 months of prior, iron overload, steatohepatitis, active inflammatory or infection hepatitis or any other condition which puts the patient at a higher risk of developing SOS.\n\nSubjects aged 1 month through 99 years will be eligible for the study. Patients who receive defibrotide and/or ursodiol for VOD/SOS prophylaxis will also be eligible for the study. At most 175 children (ages 1 month to 18 years) and 175 adults (>18 years old) can be enrolled into the study.\n\nInclusion dates: Patients seen between 1/1/2019 and 12/31/2025\nHealthy volunteers allowed\nMust have minimum age of 1 Month\nMust have maximum age of 99 Years",
    "exclusion_criteria": "Any patient who has contraindication to ultrasound shear wave elastography (e.g. unable to hold still) Adults unable to consent Pregnant women Prisoners Wards of the state",
    "miscellaneous_criteria": ""
}